SCHEMBL29669307

SCHEMBL29669307

Cc1cc2[nH]c(N)nc2c(C)c1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP6 P51161 1/20 0.55
PNP P00491 2/20 0.47
NUDT1 P36639 4/20 0.41
BRD4 O60885 1/20 0.38
MMP12 P39900 3/20 0.38
RPS6KA3 P51812 2/20 0.36
MASP2 O00187 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
AOC3 Q16853 1/20 0.35
PLAU P00749 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
BACE1 P56817 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
CYP1A2 P05177 1/20 0.35
CDK5 Q00535 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6622913 0.88 FABP6 (0.55) FABP6PNPNUDT1BRD4MMP12
SCHEMBL13135757 0.79 HTT (0.50) FABP6BRD4MEN1ALDH1A1KMT2A
SCHEMBL6581218 0.77 MEN1 (0.46) FABP6PNPMEN1ALDH1A1KMT2A
SCHEMBL14958067 0.76 MEN1 (0.34) FABP6MEN1ALDH1A1KMT2A
SCHEMBL5679402 0.76 NUDT1 (0.51) FABP6PNPNUDT1BRD4RPS6KA3
SCHEMBL2541920 0.76 CBFB (0.49) FABP6PNPNUDT1MMP12RPS6KA3
SCHEMBL19954109 0.73 KDM4E (0.42) FABP6MEN1ALDH1A1KMT2ACYP1A2
SCHEMBL6856394 0.73 PLAU (0.49) FABP6PNPNUDT1BRD4MMP12
SCHEMBL6581987 0.72 FABP6 (0.40) FABP6PNPNUDT1BRD4MMP12
SCHEMBL393703 0.71 FABP6 (1.00) FABP6NUDT1MASP2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11345681-B1 Inhibitors of fibroblast growth factor receptor kinases KINNATE BIOPHARMA INC. (US) 2022-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11345681-B1 Inhibitors of fibroblast growth factor receptor kinases FGFR1, FGFR2, FGFR3 FABP6 2400/4885PNP 1122/4885NUDT1 2535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.